Quantification of HER2 from FFPE Tumor Tissue using Targeted Mass Spectrometry (MS)

摘要

Targeted mass spectrometry was used for the simultaneous quantitation of Her2 and eleven other predictive/prognostic markers for cancer. A case study of a gallbladder cancer patient with amplified Her2 as detected by the OncoPlexDx SRM method will be presented as evidence of the diagnostic power of our assay.